Cagrilintide

Synonyms: Cagrilintide, 1415456-99-3, Amylin analog, Long-acting amylin analog, NN-9935, Cagrilintide acetate

Cagrilintide is a synthetic analog of human amylin, a peptide hormone that works alongside insulin to regulate postprandial glucose levels and signal satiety. Developed by Novo Nordisk, this long-acting amylin analog is designed for once-weekly dosing, making it a promising candidate for obesity and type 2 diabetes management. Its extended half-life is achieved through fatty acid acylation, which promotes albumin binding and slows renal clearance.

함수

• Amylin receptor agonist: Activates amylin receptors, reducing food intake and delaying gastric emptying.
• 식욕 조절: Enhances satiety signaling, leading to reduced caloric intake.
• 체중 관리: Promotes weight loss in overweight and obese individuals.
• Glycemic control: Helps regulate postprandial glucose levels.

출처 및 표준화

• 출처: Synthetic peptide, produced via solid-phase peptide synthesis.
• 표준화: Purity ≥98% (HPLC), peptide content 70-90%.
• 양식: Lyophilized powder, acetate salt.
• 응용 분야: Research on obesity, type 2 diabetes, and metabolic disorders.

문서 및 공급

• 최소 주문 수량(MOQ): 5g
• 월간 처리 능력: 1 kg
• 리드 타임: 5-10 days after order
• 문서: COA, MSDS, TDS
• 포장: Sealed vials or custom packaging

견적 요청

• 주소: 중국 산시성 시안시 메인 스트리트 280번지
• LyvBio 주식회사. — 이메일: info@lyvbio.com